Projecting the medical costs of aids and arc in the united states

Journal of Acquired Immune Deficiency Syndromes

Volumn 1, Issue 5, 1988, Pages 466-485

  Jacobson, Mark A ^c,d   Osmond, Dennis H ^b,d  

^a STANFORD UNIVERSITY   (United States)

^b Department of Epidemiology International Health ^*  (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

Acquired immune deficiency syndrome; AIDS related complex; Case projections; Cost of illness; HIV epidemiology

Indexed keywords

ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AIDS RELATED COMPLEX; COST CONTROL; COST EFFECTIVENESS ANALYSIS; ECONOMIC ASPECT; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; NONHUMAN;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AIDS-RELATED COMPLEX; COST ALLOCATION; COSTS AND COST ANALYSIS; FORECASTING; HIV SEROPOSITIVITY; HUMAN; SUPPORT, NON-U.S. GOV'T; UNITED STATES;

EID: 0024214337     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: None     Document Type: Article

References (72)

1. U.S. Dept. of Health and Human Services, Public Health Service. Coolfont report: A PHS plan for prevention and control of AIDS and the AIDS virus. Publ Health Rep 1986; 101:341-8.
2. Pascal A. The costs of treating AIDS under Medicaid: 1986-1991. Santa Monica, CA: The Rand Corporation, 1986.
3. Scitovsky AA, Rice DP. Estimates of the direct and indirect costs of acquired immunodeficiency syndrome in the United States, 1985, 1986, and 1991. Publ Health Rep 1987; 102:5-17.
4. Arno PS. The economic impact of AIDS. JAMA 1987; 258: 1376-7.
5. Kizer KW, Rodriguez J, McHolland GF. An updated quantitative analysis of AIDS in California. California Dept. of Health Services, April 1987.
6. Scitovsky AA, Cline M, Lee PR. Medical care costs of patients with AIDS in San Francisco. JAMA 1986; 256:3103-6.
7. Seage GR, Landers S, Barry A, Groopman J, Lamb GA, Epstein AM. Medical care costs of AIDS in Massachusetts. JAMA 1986; 256:3107-9.
8. Hardy AM, Rauch K, Echenberg D, Morgan WM, Curran JW. The economic impact of the first 10, 000 cases of acquired immunodeficiency syndrome in the United States. JAMA 1986; 255:209-11.
9. Andrulis DP, Beers VS, Bentley JD, Gage LS. The provision and financing of medical care for AIDS patients in U.S. public and private teaching hospitals. JAMA 1987; 258: 1343-6.
10. Equicor. 1987 hospital daily service charges. Nashville, TN: Equitable HCA Corporation, 1987.
11. Brookmeyer R, Gail MH. Minimum size of the acquired immunodeficiency syndrome (AIDS) epidemic in the United States. Lancet 1986; 2:1320-2.
12. Morgan WM, Curran JW. Acquired immunodeficiency syndrome: current and future trends. Pub Health Rep 1986; 101:459-65.
13. Centers for Disease Control. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR 1987; 36:1(S)-15(S).
14. Green-Stehr JK, Jason JM, Evatt BL. Potential effect of revising the CDC surveillance case definition for AIDS. Lancet 1988; 1:520-1.
15. Rutherford GW, Payne SF, Lemp GF. Impact of the revised AIDS case definition on AIDS reporting in San Francisco. JAMA 1988; 259:2235.
16. Department of Health and Human Services. Human immunodeficiency virus infections in the United States: a review of current knowledge and plans for expansion of HIV surveillance activities. A report to the Domestic Policy Council, November 30, 1987.
17. Moss AM, Bacchetti PB, Osmond, DH, et al. Seropositivity for HIV and the development of AIDS or AIDS related conditions: three-year follow-up of the San Francisco General Hospital Cohort. Br Med J 1988; 296:745-50.
18. Rutherford G, O’ Malley PM, Doll LS, et al. The natural history of human immunodeficiency virus infection in a cohort of homosexual and bisexual men: a 7-year prospective study. Third International AIDS Conference, Washington, D.C., 1987, Abstract M.3.1.
19. Goedert JJ, Biggar RJ, Weiss SH, et al. Three-year incidence of AIDS in five cohorts of HTLV-III-infected risk group members. Science 1986; 231:992-5.
20. Eyster ME, Mitchell HG, Ballard JO, Al-Mondhiry H, Goedert JJ. Natural history of human immunodeficiency vims infections in hemophiliacs: effects of T-cell subsets, platelet counts, and age. Ann Intern Med 1987; 107:1-6.
21. Centers for Disease Control. AIDS weekly surveillance report-United States AIDS Program. Center for Infectious Diseases, February 4, 1988.
22. Hardy AM, Starcher ET, Morgan WM, et al. Review of death certificates to assess completeness of AIDS case reporting. Publ Health Rep 1987; 102:386-91.
23. Rothenberg R, Woelfel M, Stoneburner R, et al. Survival with the acquired immunodeficiency syndrome: experience with 5, 833 cases in New York City. N Engl J Med 1987; 317:1297-303.
24. Bacchetti PB, Osmond DH, Chaisson RC, et al. Survival patterns of the first 500 patients with AIDS in San Francisco. J Infect Dis 1988; 157:1044-7.
25. Greenspan D, Greenspan JS, Hearst NG, et al. Relation of oral hairy leukoplakia to infection with the human immunodeficiency virus and the risk of developing AIDS. J Infect Dis 1987; 155:475-81.
26. Melbye M, Grossman RJ, Boedert JJ, Eyster ME, Biggar RJ. Risk of AIDS after herpes zoster. Lancet 1987; 1:728-31.
27. Centers for Disease Control. AIDS weekly surveillance report-United States AIDS Program. Center for Infectious Disease, June 1, 1987.
28. Stover DE, White DA, Romano PA, Gellene RA, Robeson WA. Spectrum of pulmonary diseases associated with the acquired immune deficiency syndrome. Am J Med 1985; 78:429-37.
29. Rainer CA, Feigal DW, Leoung G, Clement M, Wofsy C. Prognosis and natural history of Pneumocystis carinii pneumonia: indicators for early and late survival. Third International AIDS Conference, Washington, D.C., 1987, Abstract THP.154.
30. Murray JF, Felton CP, Garay SM, et al. Pulmonary complications of the acquired immunodeficiency syndrome. A report of a National Heart, Lung, and Blood Institute workshop. N Engl J Med 1984; 310:1682-8.
31. Marchevsky A, Rosen MJ, Chrystal G, Kleinerman J. Pulmonary complications of the acquired immunodeficiency syndrome: a clinicopathologic study of 70 cases. Hum Pathol 1985; 167:659-70.
32. Rosen MJ, Tow TW, Teirstein AS, Chang MT, Marchevsky A, Bottone EJ. Diagnosis of pulmonary complications of the acquired immune deficiency syndrome. Thorax 1985; 40: 571-5.
33. Heron CW, Hine AL, Pozniak AL, Swinburn CR, Johnson NM. Radiographic features in patients with pulmonary manifestations of the acquired immune deficiency syndrome. Clin Radiol 1985; 36:583-8.
34. Curtis JL, Goodman P, Hopewell PC. Noninvasive tests in the diagnostic evaluation of Pneumocystis carinii pneumonia in patients with or suspected of having the acquired immunodeficiency syndrome. Am Rev Respir Dis 1986; 133:A-182 (Abstract).
35. Murray JF, Garay SM, Hopewell PC, Mills J, Synyder GL, Stover DE. NHLBI workshop summary. Pulmonary complications of the acquired immunodeficiency syndrome: an update report of the second National Heart, Lung and Blood Institute workshop. Am Rev Respir Dis 1987; 135:504-9.
36. Bigby TD, Margolskee D, Curtis JL, et al. The usefulness of induced spectrum in the diagnosis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. Am Rev Respir Dis 1986; 133:515-8.
37. Kovacs JA, Ng VL, Masur H, et al. Diagnosis of Pneumocystis carinii pneumonia: improved detection in sputum with use of monoclonal antibodies. N Engl J Med 1988; 318:589-93.
38. Wharton JM, Coleman DL, Wofsy CB, et al. Trimethoprim-sulfamethoxazole or pentamidine for Pneumocystis carinii pneumonia in the acquried immunodeficiency syndrome: A prospective randomized trial. Ann Intern Med 1986; 105(1):37-44.
39. Gordin FM, Simon GL, Wofsy CB, Mills J. Adverse reactions to trimethoprim-sulfamethoxazole in patients with the acquired immunodeficiency syndrome. Ann Intern Med 1984; 100:495-9.
40. Medina I, Leoung G, Mills J, Hopewell P, Feigel D, Wofsy C. Oral therapy for Pneumocystis carinii pneumonia in AIDS. A randomized double blind trial of trimethoprim sulfamethoxazole versus dapsone-trimethoprim for first episode Pneumocystis carinii pneumonia in AIDS. Third International AIDS Conference, Washington, D.C., 1987, Abstract F.3.3.
41. Golden JA, Hollander H, Conte JE. Inhaled pentamidine as exclusive therapy for Pneumocystis carinii pneumonia (PCP) in the acquired immunodeficiency syndrome (AIDS). Third International AIDS Conference, Washington, D.C., 1987, Abstract TP.217.
42. Montgomery AB, Luce SM, Tanner J, et al. Aerosolized pentamidine as sole therapy for Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. Lancet 1987; 2:480-2.
43. Fahrner R, Clement MJ, Kline A, Cohen JB. Helping young people face death: resuscitation status and outcome in first episode Pneumocystis carinii pneumonia. Third International AIDS Conference, Washington, D.C., 1987, Abstract TH.3.1.
44. El Sadr W, Simberkoff MS. Prognostic factors for Pneumocystis carinii pneumonia requiring mechanical ventilation. Third International AIDS Conference, Washington, D.C., 1987, Abstract TP.163.
45. Hardy D, Wolfe PR, Gottlieb MS, Knight S, Mitsuyasu R, Young LS. Long-term follow-up of fansidar prophylaxis for Pneumocystis carinii pneumonia (PCP) in patients with AIDS. Third International AIDS Conference, Washington, D.C., 1987, Abstract THP.232.
46. Viera J. Fansidar prophylaxis of Pneumocystis carinii pneumonia in asymptomatic HIV seropositive persons and persons with ARC. Third International AIDS Conference, Washington, D.C., 1987, Abstract TP.221.
47. Metroka CE, Lange M, Braun N, O’ Sullivan M, Josefberg H, Jacobus D. Successful chemoprophylaxis for Pneumocystis carinii pneumonia with dapsone in patients with AIDS and ARC. Third International AIDS Conference, Washington, D.C., 1987, Abstract THP.231.
48. Polsky B, Gold JW, Whimbey E, et al. Bacterial pneumonia in patients with the acquired immunodeficiency syndrome. Ann Intern Med 1986:104:38-41.
49. Selwyn PA, Feingold AR, Hartel D, et al. Bacterial pneumonia and HIV infection in parenteral drug users without AIDS. Third International AIDS Conference, Washington, D.C., 1987, Abstract THP.41.
50. Manoff SB, Stoneburner RL, Milberg JA, et al. An old disease meets a new disease: tuberculosis and the acquired immunodeficiency syndrome in New York City. Third International AIDS Conference, Washington, D.C., 1987, Abstract TP.42.
51. Rodriguez SJ, Hernandez MM, Rolston KV. Diarrhea in patients with AIDS/ARC. Third International AIDS Conference, Washington, D.C., 1987, Abstract TP.147.
52. Antony MA, Brandt LJ, Klein RS, Bernstein LH. Infectious causes of diarrhea in patients with AIDS. Third International AIDS Conference, Washington, D.C., 1987, Abstract F.3.4.
53. Jacobson MA, Mills J, Serious cytomegalovirus in acquired immunodeficiency syndrome: clinical findings, diagnosis and treatment. Ann Intern Med 1988; 108:585-94.
54. Centers for Disease Control. AIDS Weekly Surveillance Report-U.S., June 1, 1987.
55. Volberding P, Feigal DW, Cutler K, Hearst N. Decreasing survival in recently diagnosed AIDS-related Kaposi’s sarcoma. Third International AIDS Conference, Washington, D.C., 1987, Abstract THP.56.
56. Fischl MA, Dickinson GM, La Voie L. Safety and efficacy of sulfamethoxazole and trimethoprim chemoprophylaxis for Pneumocystis carinii pneumonia in AIDS. JAMA 1988; 259:1185-9.
57. Snider WD, Simpson DM, Nielson S. Neurological complications of the acquired immunodeficiency syndrome. Ann Neurol 1983; 14:403-18.
58. Levy RM, Bredesen DE, Rosenblum ML. Neurological manifestations of the acquried immunodeficiency syndrome (AIDS): experience at UCSF and review of the literature. J Neurosurg 1985; 62:475-95.
59. Selik RM, Stacher ET, Curran JW. Opportunistic diseases reported in AIDS patients: frequencies, associations and trends. AIDS 1987; 1:175-82.
60. Cohn J, McMeeking A, Cohen W, Jacobs J, Holzman R. Response and survival in patients treated for presumed versus proven CNS toxoplasmoisis. Third International AIDS Conference, Washington, D.C., 1987, Abstract WP.147.
61. Mess TP, Hadley WK, Wofsy CB. Use of high dose ketoconazole in AIDS patients for prevention of relapse in cryptococcal meningitis. Third International AIDS Conference, Washington, D.C., 1987, Abstract TP.219.
62. Fishl M, Richman DD, Grieco MH, et al. The efficacy of azidothymidine in the treatment of patients with AIDS and AIDS-related complex: a double blind, placebo-controlled trial. N Engl J Med 1987; 317:185-91.
63. Zidovudine package insert. Burroughs Wellcome Company, Research Triangle Park, NC, U.S.A.
64. Wong RJ, Jacobson MA. Azidothymidine tolerance in patients with acquired immunodeficiency syndrome post-Pneumocystis carinii pneumonia. 27th Interscience Conference on Antimicrobial Agents and Chemotherapy, New York, 1987, Abstract 387.
65. Barbara DJ, Emanuele T, Fredenburg L, Luby JP. Open trial of azidothymidine in AIDS patients at Parkland Memorial Hospital. Third International AIDS Conference, Washington, D.C., 1987, Abstract THP.229.
66. Chiuten DF, Mansell P, McCrory L, Kurowski P, Hernandez M, Rodriguez S. Effects of 3'-azido-3'-deoxythymidine in patients with acquired immunodeficiency syndrome post-Pneumocystis carinii pneumonia infection. Third International AIDS Conference, Washington, D.C., 1987, Abstract THP.234.
67. Lang W, Anderson RE, Perkins H, et al. Clinical, immunologic and serologic findings in men at risk for acquired immunodeficiency syndrome: The San Francisco Men’s Health Study. JAMA 1987; 257:326-30.
68. Richman D, Fischl MA, Greico MH, et al. The toxicity of azidothymidine in the treatment of patients with AIDS and AIDS-related complex: a double-blind, placebo-controlled trial. N Engl J Med 1987; 317:192-7.
69. Jacobson MA, Mills J. Estimating long-term consequences of azidothymidine therapy of human immunodeficiency virus infection using the Delphi group opinion method. Arch AIDS Res (in press).
70. Abrams DI. Lymphadenopathy syndrome in male homosexuals. In: Gallin JI, Fauci AJ, eds. Advances in host defense mechanisms, Vol. 5. New York: Raven Press, 1985:75-97.
71. Bloom DE, Carliner C. The economic impact of AIDS in the United States. Science 1988; 239:604-10.
72. Shanti Project. Overview of program costs and services. San Francisco, 1987.